ANPCY
Price
$1.47
Change
+$0.27 (+22.50%)
Updated
Dec 2 closing price
VRCDF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Ad is loading...

ANPCY vs VRCDF

Header iconANPCY vs VRCDF Comparison
Open Charts ANPCY vs VRCDFBanner chart's image
ANGLE
Price$1.47
Change+$0.27 (+22.50%)
Volume$402
CapitalizationN/A
VERICI DX
Price$0.03
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
ANPCY vs VRCDF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANPCY vs. VRCDF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANPCY is a Hold and VRCDF is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ANPCY: $1.47 vs. VRCDF: $0.03)
Brand notoriety: ANPCY and VRCDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANPCY: 36% vs. VRCDF: 3%
Market capitalization -- ANPCY: $48.56M vs. VRCDF: $22.99M
ANPCY [@Medical Specialties] is valued at $48.56M. VRCDF’s [@Medical Specialties] market capitalization is $22.99M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANPCY’s FA Score shows that 0 FA rating(s) are green whileVRCDF’s FA Score has 1 green FA rating(s).

  • ANPCY’s FA Score: 0 green, 5 red.
  • VRCDF’s FA Score: 1 green, 4 red.
According to our system of comparison, ANPCY is a better buy in the long-term than VRCDF.

Price Growth

ANPCY (@Medical Specialties) experienced а 0.00% price change this week, while VRCDF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.11%. For the same industry, the average monthly price growth was +3.91%, and the average quarterly price growth was +5.34%.

Industries' Descriptions

@Medical Specialties (-2.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
ANPCY($48.6M) has a higher market cap than VRCDF($23M). ANPCY YTD gains are higher at: -3.289 vs. VRCDF (-72.727). VRCDF has higher annual earnings (EBITDA): -10.35M vs. ANPCY (-15.72M). ANPCY has more cash in the bank: 31.8M vs. VRCDF (15.7M). VRCDF has less debt than ANPCY: VRCDF (0) vs ANPCY (2.34M). ANPCY has higher revenues than VRCDF: ANPCY (1.01M) vs VRCDF (0).
ANPCYVRCDFANPCY / VRCDF
Capitalization48.6M23M211%
EBITDA-15.72M-10.35M152%
Gain YTD-3.289-72.7275%
P/E RatioN/AN/A-
Revenue1.01M0-
Total Cash31.8M15.7M203%
Total Debt2.34M0-
FUNDAMENTALS RATINGS
ANPCY: Fundamental Ratings
ANPCY
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ANPCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANPCY has been loosely correlated with ANPCF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ANPCY jumps, then ANPCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANPCY
1D Price
Change %
ANPCY100%
N/A
ANPCF - ANPCY
56%
Loosely correlated
N/A
AHCO - ANPCY
24%
Poorly correlated
+0.40%
NVRO - ANPCY
22%
Poorly correlated
-2.41%
VRCDF - ANPCY
21%
Poorly correlated
N/A
ANSLY - ANPCY
11%
Poorly correlated
N/A
More

VRCDF and

Correlation & Price change

A.I.dvisor tells us that VRCDF and AVNS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRCDF and AVNS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCDF
1D Price
Change %
VRCDF100%
N/A
AVNS - VRCDF
32%
Poorly correlated
-4.11%
TNON - VRCDF
25%
Poorly correlated
-1.55%
BITGF - VRCDF
21%
Poorly correlated
N/A
ANPCY - VRCDF
21%
Poorly correlated
N/A
ITGDF - VRCDF
4%
Poorly correlated
N/A
More